Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Technische Universität München
ClinicalTrials.gov Identifier:
NCT01198808
First received: September 8, 2010
Last updated: January 16, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)